Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parkinson´s day-clinic: which patients should be selected and what services should be offered for successful therapy?

Journal of neural transmission (Vienna, Austria : 1996)·2025
Same author

Diagnostic and therapeutic challenges in PD-associated non-motor symptoms: the roles of neurologists and consultant physicians.

Journal of neural transmission (Vienna, Austria : 1996)·2024
Same author

Correction to: Role of dopamine agonists in Parkinson's disease therapy.

Journal of neural transmission (Vienna, Austria : 1996)·2023
Same author

Role of dopamine agonists in Parkinson's disease therapy.

Journal of neural transmission (Vienna, Austria : 1996)·2023
Same author

Disruption of NREM sleep and sleep-related spatial memory consolidation in mice lacking adult hippocampal neurogenesis.

Scientific reports·2020
Same author

[Dystonia Non-Motor Symptoms Questionnaire (DNMSQuest) for assessment of non-motor symptoms in dystonia : Intercultural adaptation in the German language].

Der Nervenarzt·2020
Same journal

Correction: Long-term neurological outcome after hematopoietic stem cell transplant in juvenile Krabbe disease.

Journal of neurology·2026
Same journal

Radiological and FDG-PET imaging features of Epstein-Barr virus-positive primary central nervous system lymphomas.

Journal of neurology·2026
Same journal

Unexpected widespread amyloid PET positivity in a patient with CADASIL.

Journal of neurology·2026
Same journal

Movement disorders in GLUT1 deficiency syndrome: a systematic review of the literature.

Journal of neurology·2026
Same journal

Detailed clinical characteristics of musical hallucinations in 81 patients.

Journal of neurology·2026
Same journal

The dual role of mTOR in multiple sclerosis pathophysiology: a systematic review.

Journal of neurology·2026
See all related articles

Related Experiment Videos

Depression in Parkinson's disease.

J Schwarz1, P Odin, C Buhmann

  • 1Department of Neurology, University of Leipzig, Liebigstr. 20, 04103 Leipzig, Germany. johannes@caltech.edu

Journal of Neurology
|May 12, 2011
PubMed
Summary
This summary is machine-generated.

Parkinson's disease (PD) depression is common and impacts quality of life, but can be mistaken for other symptoms. More research is needed on diagnosing and treating depression in PD patients.

Related Experiment Videos

Area of Science:

  • Neurology
  • Psychiatry

Background:

  • Depression is a significant non-motor symptom in Parkinson's disease (PD).
  • Its impact on patient quality of life is substantial.
  • Depression in PD can be difficult to diagnose due to confounding motor and other non-motor symptoms like apathy, anxiety, and dementia.

Purpose of the Study:

  • To summarize expert opinion on diagnosing and treating depressive symptoms in Parkinson's disease.
  • To highlight the challenges in differentiating depression from other PD symptoms.

Main Methods:

  • Expert opinion synthesis.
  • Review of available data and clinical experience.

Main Results:

  • Depression is a frequent and impactful non-motor symptom in Parkinson's disease.
  • Diagnostic and treatment strategies for depression in PD are not well-established.
  • Confounding factors like akinesia, apathy, anxiety, and dementia complicate diagnosis.

Conclusions:

  • Further research is required for specific diagnostic tools and treatments for depression in Parkinson's disease patients.
  • Clinical experience suggests a need for careful evaluation to distinguish depression from other PD-related symptoms.